Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/7y5t-jy48

technical paper

ENDO 2021

March 21, 2021

Live on Underline

The Solution for a Yet Unsolvable Problem? Dextroamphetamine Treatment for Acquired or Genetic Hypothalmic Obesity

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
- An RCT of Tesomet in Acquired Hypothalmic Obesity
technical paper

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity - An RCT of Tesomet in Acquired Hypothalmic Obesity

ENDO 2021

21 March 2021

Similar lecture

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)
technical paper

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved